Anagrelid
Anagrelid Nordic is used to reduce the number of platelets (thrombocytes) in the blood in patients with essential thrombocythaemia, a condition where the body produces too many platelets. A large increase in the number of platelets in the blood can cause problems with blood circulation and blood clotting. Reducing the number of platelets reduces the risk of serious complications.
Before taking Anagrelid Nordic, tell your doctor:
If you are taking aspirin (acetylsalicylic acid) at the same time, there is an increased risk of serious bleeding (haemorrhage) (see section “Anagrelid Nordic with other medicines”).
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, and about any medicines you plan to take. Tell your doctor if you are taking any of the following medicines:
The effect of Anagrelid Nordic or the other medicines may be affected if they are taken together. If you are in doubt, consult your doctor or pharmacist.
Food delays the absorption of Anagrelid Nordic but does not affect its efficacy. You should not drink grapefruit juice as it may prolong the time it takes for the medicine to be removed from the body.
If you are pregnant or planning to become pregnant, tell your doctor. Women who are pregnant should not take Anagrelid Nordic. Women of childbearing age should use effective contraception while taking Anagrelid Nordic. If you are breast-feeding or planning to breast-feed, tell your doctor. You should not take Anagrelid Nordic while breast-feeding. You should stop breast-feeding if you take Anagrelid Nordic.
Some patients taking Anagrelid Nordic have experienced dizziness. If you experience dizziness, do not drive or operate machinery.
This medicine contains lactose. If you have been told that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always take this medicine exactly as your doctor has told you. Your doctor will decide the most suitable dose for you. The usual starting dose of Anagrelid Nordic is between 0.5 mg and 1 mg once daily for at least one week. After this period, your doctor may increase or decrease the number of tablets to be taken to determine the most suitable dose for you, which will provide the best effect. The maximum dose is 5 mg per day. The tablet can be divided into equal doses. Do not take more tablets than your doctor has recommended.
Since experience with Anagrelid Nordic in children and adolescents is limited, this medicine should not be used in children and adolescents under 18 years of age.
If you have liver or kidney disease, your doctor will decide whether you can be treated with Anagrelid Nordic.
Take the tablets with a sufficient amount of liquid.
If you have taken more Anagrelid Nordic than you should, contact your doctor or pharmacist immediately. Show them the pack of Anagrelid Nordic. High doses of the medicine may cause a decrease in blood pressure, accompanied by dizziness, nausea, vomiting and disturbances in heart rhythm.
Take the tablet as soon as you remember. Take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.
Do not stop taking Anagrelid Nordic without consulting your doctor. After stopping treatment with Anagrelid Nordic, the number of platelets will return to pre-treatment levels within 14 days. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Anagrelid Nordic can cause side effects, although not everybody gets them. If you experience any serious side effects, or any side effects not listed in this leaflet, tell your doctor or pharmacist. Serious side effects:
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very common (may affect more than 1 in 10 people):
Headache.
Common (may affect up to 1 in 10 people):
Decreased number of red blood cells (anaemia), bleeding under the skin, swelling, dizziness of inner ear origin, insomnia, abnormal sensations or feelings, such as tingling or “pins and needles”, rapid heartbeat, irregular or forceful heartbeat (palpitations), high blood pressure, nosebleeds, diarrhoea, nausea, indigestion, rash, back pain, fatigue.
Uncommon (may affect up to 1 in 100 people):
Decreased number of platelets (thrombocytopenia), bleeding, bruising, weight gain, depression, nervousness, dry mouth, migraine, conjunctivitis, visual disturbances, ringing in the ears (tinnitus), fainting, shortness of breath or difficulty breathing, pneumonia, increased blood pressure in the lungs, causing symptoms such as shortness of breath, fatigue, chest pain or swelling, vomiting, flatulence, stomach pain, constipation, hair loss, itching, joint pain, muscle pain, cystitis, pain, weakness.
Rare (may affect up to 1 in 1,000 people):
Severe chest pain (angina pectoris), dizziness when standing up (especially from a sitting or lying position), loss of appetite, gastritis (symptoms include pain, nausea, vomiting), fluid accumulation around the lungs, pneumonia, asthma, increased need to urinate at night, increased activity of liver enzymes, flu-like symptoms, chills, general feeling of being unwell.
Side effects with unknown frequency:
Irregular heart rhythm (torsades de pointes), respiratory disease causing scarring of lung tissue (symptoms include shortness of breath), interstitial nephritis.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the national reporting system via the Medicines and Healthcare products Regulatory Agency (MHRA) Yellow Card Scheme (www.mhra.gov.uk/yellowcard). By reporting side effects, you can help provide more information on the safety of this medicine.
Store the blister in the outer carton to protect from light. Store the bottle tightly closed to protect from light. Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle, carton or blister after EXP. The expiry date refers to the last day of that month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
The active substance is anagrelide.
Anagrelid Nordic, 0.5 mg:Each tablet contains 0.5 mg anagrelide (as anagrelide hydrochloride monohydrate)
Anagrelid Nordic, 0.75 mg:Each tablet contains 0.75 mg anagrelide (as anagrelide hydrochloride monohydrate)
Anagrelid Nordic, 1 mg:Each tablet contains 1 mg anagrelide (as anagrelide hydrochloride monohydrate)
The other ingredients are lactose anhydrous, povidone (K30), crospovidone (type B), microcrystalline cellulose and magnesium stearate.
Anagrelid Nordic, 0.5 mg, are white to almost white, round tablets, approximately 6.5 mm in diameter, with “0.5” engraved on one side and a score line on the other side.
Anagrelid Nordic, 0.75 mg, are white to almost white, round tablets, approximately 8 mm in diameter, with “0.75” engraved on one side and a score line on the other side.
Anagrelid Nordic, 1 mg, are white to almost white, round tablets, approximately 9 mm in diameter, with “1.0” engraved on one side and a score line on the other side.
The tablets can be divided into equal doses.
Polyethylene bottles with a child-resistant closure, containing 100 tablets.
PVC/PVDC/Aluminium blisters in packs containing 100 tablets.
Nordic Group B.V.
Siriusdreef 41
2132 WT Hoofddorp
Netherlands
QPharma AB
Agneslundsvägen 27
21215 Malmö
Sweden
Austria:
Anagrelid Nordic 0,5 mg Tabletten
Anagrelid Nordic 0,75 mg Tabletten
Anagrelid Nordic 1 mg Tabletten
Bulgaria:
Anagrelid Nordic 0.5 mg tablets
Анагрелид Нордик 0,5 mg, таблетки
Anagrelid Nordic 0.75 mg tablets
Анагрелид Нордик 0,75 mg, таблетки
Anagrelid Nordic 1 mg tablets
Анагрелид Нордик 1 mg, таблетки
Italy:
REDESK
Czech Republic:
Anagrelid Nordic
Poland:
Anagrelid Nordic
Romania:
Anagrelidă Nordic 0,5 mg, comprimate
Anagrelidă Nordic 0,75 mg, comprimate
Anagrelidă Nordic 1,0 mg, comprimate
Slovakia:
Anagrelid Nordic 0,5 mg tablets
Anagrelid Nordic 0,75 mg tablets
Anagrelid Nordic 1,0 mg tablets
Date of last revision of the leaflet:2020-04-08
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.